kaiser permanente --ohio0214253
29099 health campus drive
suite230
44145
August 01, 1998
Most of the clinical experience with irinotecan (CPT-11 [Camptosar]) has been with either a weekly or an every-3-week schedule. Recent phase I trials have explored new routes and schedules of administration. One approach